- Philippine Congress backs body cameras for police in bloody war on dru
- China defends trade with U.S. as Trump set to brand it a competitor
- Israel strikes Hamas targets in Gaza after Palestinian rocket attacks
- Belgian trial of Paris attack suspect postponed to February 5
- India's muted response to Trump's Jerusalem move stokes Arab unease
- Gunmen seize building in Afghan capital, firing on security forces
- How to buy and sell bitcoin - CNN Video
- Peru VP says committed to governing if president ousted
- Myanmar government says case against Reuters journalists can proceed
- Thomas Fire on course to become California's largest-ever wildfire
- Erdogan defies Trump, says Turkey has own embassy plans for Jerusalem
- Bitcoin futures trading just got a lot bigger
- Moscow says U.S. and North Korea should start a dialogue: RIA
- Australia's embattled Turnbull seen weighing cabinet reshuffle to expl
- At least 61 dead after days of violence in Ethiopia's Oromiya region
- Philippines says Maoist rebels attacked soldiers on typhoon relief dut
- U.S. taxpayers rush to claim deductions under threat from tax bill
- Tiny stem cell companies close in on major heart disease goals
- OAS says Honduran presidential election should be redone
- India ruling party pulls ahead in election in Modi state after tight r
Exclusive: Mednax fielding takeover interest from buyout firms - sources
(Reuters) - Mednax Inc, a U.S. healthcare network operator targeted by activist hedge fund Elliott Management Corp, is fielding acquisition interest from several private equity firms, according to people familiar with the matter.
The approaches to Mednax by private equity firms come after Elliott disclosed a 7 percent stake in the company last month and said it would discuss several options to boost value for shareholders, including a potential sale of the company.
Mednax is working with Bank of America Corp to handle the approaches by private equity firms, that include Carlyle Group LP, the sources said this week. Mednax has not yet launched a process to sell itself, and there is no certainty any deal will occur, the sources added.
Mednax did not immediately respond to requests for comment. Bank of America and Carlyle declined to comment.
Reporting by Carl O'Donnell and Liana B. Baker in New York; Editing by Andrew Hay
Our Standards:The Thomson Reuters Trust Principles.